C12N 15/1041
Ribosome/polysome display
Official title: {Ribosome/Polysome display, e.g. SPERT, ARM}
C12N15/1041 (Ribosome/polysome display) appears on 75 US grants and 108 published applications in this corpus.
Search patents in C12N- Granted patents
- 75
- Published applications
- 108
- Assignees
- 69
- Inventors
- 206
- Latest grant
- 16 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 7 |
| 2003 | 3 | 3 |
| 2004 | 1 | 2 |
| 2005 | 1 | 4 |
| 2006 | 1 | 4 |
| 2007 | 0 | 3 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 1 | 7 |
| 2011 | 2 | 3 |
| 2012 | 3 | 1 |
| 2013 | 2 | 9 |
| 2014 | 7 | 7 |
| 2015 | 1 | 3 |
| 2016 | 7 | 9 |
| 2017 | 8 | 6 |
| 2018 | 6 | 6 |
| 2019 | 6 | 7 |
| 2020 | 4 | 5 |
| 2021 | 6 | 4 |
| 2022 | 3 | 5 |
| 2023 | 0 | 2 |
| 2024 | 3 | 4 |
| 2025 | 2 | 3 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Devices and methods for display of encoded peptides, polypeptides, and proteins on DNA16 Sep 2025US 12,416,100 B2The Board of Trustees of the Leland Stanford Junior University
- CoV-2 (CoV-n) antibody neutralizing and CTL vaccines using protein scaffolds and molecular evolution8 Apr 2025US 12,269,846 B2
- Single cell bar-coding for antibody discovery29 Oct 2024US 12,129,462 B2AbVitro LLC
- MRNA display antibody library and methods27 Feb 2024US 11,912,756 B2NantBio, Inc.
- Generating recombinant affinity reagents with arrayed targets27 Feb 2024US 11,913,138 B2Arizona Board of Regents on behalf of Arizona State University
- Methods, systems, and compositions of generating and analyzing polypeptide libraries2 Jul 2026US 2026/0185080 A1Protillion Biosciences, Inc.
- Methods, systems, and compositions of generating and analyzing polypeptide libraries2 Jul 2026US 2026/0185081 A1Protillion Biosciences, Inc.
- Methods and compositions for high-throughput discovery of peptide-mhc targeting binding proteins24 Jul 2025US 2025/0236862 A1Massachusetts Institute of Technology
- Method for screening for sequence that regulates display efficiency in polynucleotide presentation method29 May 2025US 2025/0171770 A1National University Corporation Tokai National Higher Education and Research System
- Protease-cleavable masked antibodies30 Jan 2025US 2025/0034274 A1Daiichi Sankyo Company, Limited
Most cited
By later US patents
- Cell-free synthesis and isolation of novel genes and polypeptides191US 5,643,768 AOptein, Inc. · 1997
- Cell-free synthesis and isolation of novel genes and polypeptides145US 5,658,754 AOptein, Inc. · 1997
- Systematic polypeptide evolution by reverse translation91US 5,843,701 ANeXstar Pharmaceticals, Inc. · 1998
- Systematic polypeptide evolution by reverse translation65US 6,194,550 B12001
- Ribosome complexes as selection particles for in vitro display and evolution of proteins58US 6,620,587 B1Discerna Limited · 2003